Cover Story
By Matthew Bin Han Ong
Utilization data compiled by Flatiron Health and made available to The Cancer Letter make it possible to visualize the dramatic uptake of immunotherapy drugs in the academic and community settings.
In Brief
Drugs & Targets
Trending Stories
- Iowa’s Mark Burkard sees a role for data science in bringing clinical trials to rural clinics
The state has the second highest (and rising) cancer rates in the U.S. - At his 25-year “anniversary party,” Pazdur invites Califf and past FDA commissioners to talk about political interference
- How the 2024 elections can impact cancer policy
- GRAIL’s woes raise questions about the prospects of MCDs and standards for their evaluation
- “Less Radical” podcast: Resistance to change, a data scandal
- FDA extends shelf-life for IV fluids in shortage after Hurricane Helene